Medium sized company of 140+ people listed on the AIM market of the London Stock Exchange providing reagents to the life science market.
To build product portfolio and to identify and enter into exclusive sales rights deals.
Identified, progressed, negotiated and closed the first exclusive product line acquisition deals to the value of over $2M; identified key market data for strategic and tactical business planning purposes; identified, progressed, negotiated and closed 22 non-exclusive OEM deals and the first exclusive sales rights deals with 4 external companies to gain access to their existing and future products; identified and introduced new sales channels and product types to increase revenues; led change process to enable doubling of the rate of new product introduction.
See Services Offered and Testimonials for more details.
Contact Us to discuss how we can help you.
Return to the Case Studies page or move to Case Study 2